SUNLINK HEALTH SYSTEMS INC (SSY) Fundamental Analysis & Valuation
NYSEARCA:SSY • US86737U1025
Current stock price
1.115 USD
+0.16 (+16.15%)
At close:
1.0701 USD
-0.04 (-4.03%)
After Hours:
This SSY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SSY Profitability Analysis
1.1 Basic Checks
- In the past year SSY was profitable.
- In the past year SSY has reported a negative cash flow from operations.
- In the past 5 years SSY reported 4 times negative net income.
- In multiple years SSY reported negative operating cash flow during the last 5 years.
1.2 Ratios
- SSY has a Return On Assets of 9.87%. This is amongst the best in the industry. SSY outperforms 93.27% of its industry peers.
- Looking at the Return On Equity, with a value of 12.86%, SSY belongs to the top of the industry, outperforming 80.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.87% | ||
| ROE | 12.86% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- SSY's Profit Margin of 5.55% is fine compared to the rest of the industry. SSY outperforms 79.81% of its industry peers.
- SSY has a better Gross Margin (43.05%) than 70.19% of its industry peers.
- In the last couple of years the Gross Margin of SSY has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 5.55% | ||
| GM | 43.05% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.67%
2. SSY Health Analysis
2.1 Basic Checks
- SSY does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for SSY has been increased compared to 1 year ago.
- Compared to 5 years ago, SSY has more shares outstanding
- There is no outstanding debt for SSY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 2.88 indicates that SSY is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 2.88, SSY is doing good in the industry, outperforming 61.54% of the companies in the same industry.
- SSY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.88 |
ROIC/WACCN/A
WACC8.9%
2.3 Liquidity
- SSY has a Current Ratio of 3.91. This indicates that SSY is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 3.91, SSY belongs to the top of the industry, outperforming 88.46% of the companies in the same industry.
- SSY has a Quick Ratio of 3.50. This indicates that SSY is financially healthy and has no problem in meeting its short term obligations.
- SSY has a Quick ratio of 3.50. This is amongst the best in the industry. SSY outperforms 88.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.91 | ||
| Quick Ratio | 3.5 |
3. SSY Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 125.41% over the past year.
- The Revenue for SSY has decreased by -12.45% in the past year. This is quite bad
- SSY shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.58% yearly.
EPS 1Y (TTM)125.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.89%
Revenue 1Y (TTM)-12.45%
Revenue growth 3Y-7.28%
Revenue growth 5Y-6.58%
Sales Q2Q%-1.86%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. SSY Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 4.29, which indicates a rather cheap valuation of SSY.
- 99.04% of the companies in the same industry are more expensive than SSY, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of SSY to the average of the S&P500 Index (25.71), we can say SSY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.29 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. SSY Dividend Analysis
5.1 Amount
- No dividends for SSY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SSY Fundamentals: All Metrics, Ratios and Statistics
1.115
+0.16 (+16.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-14 2025-05-14
Earnings (Next)09-29 2025-09-29
Inst Owners11.33%
Inst Owner ChangeN/A
Ins Owners28.31%
Ins Owner Change0%
Market Cap7.85M
Revenue(TTM)31.09M
Net Income(TTM)1.73M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.29 | ||
| Fwd PE | N/A | ||
| P/S | 0.25 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.59 | ||
| P/tB | 0.64 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.26
EY23.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS4.42
BVpS1.9
TBVpS1.74
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.87% | ||
| ROE | 12.86% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 5.55% | ||
| GM | 43.05% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.67%
F-Score4
Asset Turnover1.78
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 48.16% | ||
| Cap/Sales | 3.03% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.91 | ||
| Quick Ratio | 3.5 | ||
| Altman-Z | 2.88 |
F-Score4
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)133.35%
Cap/Depr(5y)134.66%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.45%
Revenue growth 3Y-7.28%
Revenue growth 5Y-6.58%
Sales Q2Q%-1.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-451.48%
OCF growth 3YN/A
OCF growth 5YN/A
SUNLINK HEALTH SYSTEMS INC / SSY Fundamental Analysis FAQ
What is the ChartMill fundamental rating of SUNLINK HEALTH SYSTEMS INC (SSY) stock?
ChartMill assigns a fundamental rating of 4 / 10 to SSY.
Can you provide the valuation status for SUNLINK HEALTH SYSTEMS INC?
ChartMill assigns a valuation rating of 2 / 10 to SUNLINK HEALTH SYSTEMS INC (SSY). This can be considered as Overvalued.
What is the profitability of SSY stock?
SUNLINK HEALTH SYSTEMS INC (SSY) has a profitability rating of 3 / 10.
Can you provide the financial health for SSY stock?
The financial health rating of SUNLINK HEALTH SYSTEMS INC (SSY) is 8 / 10.